These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Immunologic factors and clinical activity in systemic lupus erythematosus. Schur PH; Sandson J N Engl J Med; 1968 Mar; 278(10):533-8. PubMed ID: 4866347 [No Abstract] [Full Text] [Related]
26. Lupus erythematosus: an autoimmune disease of the nervous system? Burton RC; McDuffie FC; Mulder DW Res Publ Assoc Res Nerv Ment Dis; 1971; 49():197-214. PubMed ID: 4109092 [No Abstract] [Full Text] [Related]
27. [Our experience in the study of nuclear and antinuclear constituant antibodies in rheumatology]. Kahn MF; Dryll A; de Seze S J Belge Rhumatol Med Phys; 1967; 22(4):217-30. PubMed ID: 4185873 [No Abstract] [Full Text] [Related]
28. Systemic lupus erythematosus: antinuclear serology and cell-mediated immunity in the light of clinico-hematologic diagnostic criteria. Preliminary communication. Bitter T Schweiz Med Wochenschr; 1971 Feb; 101(6):181-6. PubMed ID: 4104947 [No Abstract] [Full Text] [Related]
30. [Differentiation with immunofluorescence of complement fixing and non-fixing antinuclear factors in patients with and without disseminated lupus erythematosus]. Peltier AP Pathol Biol; 1968 Apr; 16(7):439-44. PubMed ID: 4882383 [No Abstract] [Full Text] [Related]
31. [Diagnostic significance of antinuclear antibody in lupus erythematosus (with cases report) (author's transl)]. Shen JX Zhonghua Kou Qiang Ke Za Zhi; 1979 Jun; 14(2):101-3. PubMed ID: 318021 [No Abstract] [Full Text] [Related]
32. [Antinuclear factors in systemic lupus erythematosus]. Cossermelli W; Gomide WS; Pastor EM; Belliboni N; de Almeida TV AMB Rev Assoc Med Bras; 1978 Dec; 24(12):421-3. PubMed ID: 85319 [No Abstract] [Full Text] [Related]
33. [Current immunological diagnosis of collagenoses. I. Systemic lupus erythematosus and systemic scleroderma]. Jarzabek-Chorzelska M; Kołacińska-Strasz Z; Błaszczyk M; Chorzelski T; Jabłońska S Przegl Dermatol; 1987; 74(6):421-30. PubMed ID: 3330246 [No Abstract] [Full Text] [Related]
34. [Clinical significance of combined detection of 7 kinds of antinuclear antibodies with immunoblotting techniques]. Qing Z Hunan Yi Ke Da Xue Xue Bao; 1997; 22(4):373-4. PubMed ID: 9868105 [No Abstract] [Full Text] [Related]
35. A subset of antibodies from the sera of patients with systemic lupus erythematosus react with vimentin and DNA. Sánchez A; Ossorio C; Alvaro-Gracia JM; Padilla R; Avila J J Rheumatol; 1990 Feb; 17(2):205-9. PubMed ID: 1690805 [TBL] [Abstract][Full Text] [Related]
37. [Is there any relationship between myasthenia gravis and disseminated lupus erythematosus?]. Fucík J; Strejcek J Munch Med Wochenschr; 1970 Jul; 112(31):1408-11. PubMed ID: 4194245 [No Abstract] [Full Text] [Related]
38. [Optimizing the clinical value of polyreactive autoantibodies to double-stranded DNA]. Haberhauer G; Chlud K; Isovits D Z Gesamte Inn Med; 1989 Nov; 44(21):652-4. PubMed ID: 2692314 [TBL] [Abstract][Full Text] [Related]
39. [Bases and practical significance of antiglobulin consumption test for the demonstration of autoimmune phenomena]. Vorlaender KO Dtsch Med Wochenschr; 1967 Jun; 92(24):1111-3. PubMed ID: 4165122 [No Abstract] [Full Text] [Related]
40. [Immunoglobulins and autoantibodies. (Characterization studies of some autoantibodies and clinical observations)]. Bonomo L G Mal Infett Parassit; 1966 Dec; 18(12):Suppl:993-1004. PubMed ID: 4173183 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]